Register now and participate in the SCOPE of Pain online activity at: www.scopeofpain.com
To receive information about our upcoming activities, please provide us with your name and email.
What is SCOPE of Pain?
SCOPE of Pain is a series of continuing medical education/continuing nursing education activities designed to help you safely and effectively manage patients with chronic pain, when appropriate, with opioid analgesics. Our program consists of:
- A 3-module cased-based online activity; and
- Live conferences held around the US
The FDA has mandated manufacturers of extended release/long-acting (ER/LA) opioid analgesics, as part of a comprehensive Risk Evaluation and Mitigation Strategy (REMS), to make available comprehensive prescriber education in the safe use of these medications based on the FDA curriculum known as the Blueprint for Prescriber Education for Extended Release and Long-Acting Opioid(ER/LA) Analgesics. Our curriculum covers all aspects of this blueprint and more to provide a comprehensive educational program.
Who is this for?
Physicians, nurse practitioners, physician assistants, registered nurses, nurses, dentists, pharmacists and allied healthcare professionals
Why do I need SCOPE of Pain training?
Chronic pain affects approximately 100 million in the US, making it one of the most common reasons for patients to seek medical care. Unfortunately, pain management, including the appropriate use of opioids, is not well covered in medical training. Moreover, there are inadequate numbers of pain management specialists to help generalist providers manage these patients.
Partly in response to the problem of under-treatment of pain, over the past decade there has been a four-fold increase in opioid prescribing. During the same time period there was a four-fold increase in unintentional opioid overdose deaths and a five-fold increase in substance abuse treatment admissions for prescription opioid addiction.
Providers who prescribe ER/LA opioid analgesics to treat chronic pain are in a key position to balance the benefits and risks of chronic opioid therapy (COT). However, providers struggle with the need to assist their patients with adequate management of chronic pain while confronting the risks associated with opioid prescribing. Our educational program looks to address that need. Strategies for multidisciplinary, inter-professional care are addressed in this curriculum.
Daniel P. Alford, MD, MPH, FACP, FASAM
Associate Professor of Medicine
Boston University School of Medicine
Boston Medical Center
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this enduring material CME activity for a maximum of 3 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
CNE Contact Hours: 3, all of which is pharmacology credit worthy
This activity was planned in collaboration with the Council of Medical Specialty Societies and the Federation of State Medical Boards.
American Academy of Family Physicians (AAFP) Credits
This enduring material activity, SCOPE of Pain: Safe and Competent Opioid Prescribing Education, has been reviewed and is acceptable for up to 3 Prescribed credits by the American Academy of Family Physicians. AAFP certification begins March 1, 2013. Term of approval is for one year from this date with the option of yearly renewal. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Risk Management and Pain Management Credits
Boston University School of Medicine designates this for three hours of risk management and opioid education based on our educational requirements.
Please check with your licensing board to determine if this activity will fulfill your state’s specific requirements.
Disclosure of Support
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies. Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration.